in 1999 drug manufacturers introduced a class of nsaids called cox2 inhibitors or coxibsthe drugs were avidly promoted directly to the consumers and became bestsellers from the startarthritis sufferers were eager to take medications that eased joint pain with less risk of causing gastrointestinal pain bleeding and other sideeffectsin the year after their introduction doctors wrote over 100 million prescriptions for celecoxib celebrex and rofecoxib vioxxcelebrex is the sixth bestselling drug with sales of more than us 4 billion since its debut in 1999vioxx had sales of us 26 billion in 2001however the coxibs increase the risk of heart attacks and strokes and their price in the usa is obscenethe manufacturers faced a possibly complicit toothless and bloodless fda and used every maneuvering to fleece the patientswe must now reflect on attitudes that we thought only belong to the tobacco industryfortunately safe and active alternatives exist